HIGHLIGHTS
- who: Nuha Bazeer and collaborators from the Institute for Health and Care Excellence, for UK have published the paper: Economic evaluation of tranexamic acid for the treatment of acute gastrointestinal bleeding: a cost- effectiveness analysis using data from the HALT- IT randomised controlled trial, in the Journal: BMJ Open 2022;12:e060505. of /2022/
- how: The model consists of two health states alive and dead as shown in figure 1. The probabilistic results are presented on a cost- effectiveness plane and as a cost- effectiveness acceptability curve (CEAC). Patient and public involvement Patient and public . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.